212 related articles for article (PubMed ID: 35832830)
21. Neoadjuvant Immunotherapy Combined Chemotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Esophageal Squamous Cell Carcinoma: A Propensity Score-Matched Study.
Hong ZN; Weng K; Peng K; Chen Z; Lin J; Kang M
Front Oncol; 2021; 11():797426. PubMed ID: 34970498
[TBL] [Abstract][Full Text] [Related]
22. Lymph node ratio is a prognostic indicator for locally advanced esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy.
Chen P; Wang L; Yang X; Feng J
Biomol Biomed; 2024 Jan; 24(1):159-169. PubMed ID: 37597214
[TBL] [Abstract][Full Text] [Related]
23. A propensity score-matched analysis of neoadjuvant chemoimmunotherapy versus surgery alone for locally advanced esophageal squamous cell carcinoma.
Wang K; Liang Y; Huang J; Xie X; Wu D; Chen B; Wang K; Shen Z; Li Y; Wang W; Hu X; Wang M
J Surg Oncol; 2023 Aug; 128(2):207-217. PubMed ID: 37036218
[TBL] [Abstract][Full Text] [Related]
24. Neoadjuvant PD-1 blockade combined with chemotherapy is not superior to neoadjuvant chemotherapy alone in resectable locally advanced esophageal carcinoma.
Cheng D; Zhao W; Chen R; Li D; Tang S; Fang C; Ji M
World J Surg Oncol; 2023 Feb; 21(1):33. PubMed ID: 36737768
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Radiomics Nomogram Model for Predicting Postoperative Recurrence in Patients With Esophageal Squamous Cell Cancer Who Achieved pCR After Neoadjuvant Chemoradiotherapy Followed by Surgery.
Qiu Q; Duan J; Deng H; Han Z; Gu J; Yue NJ; Yin Y
Front Oncol; 2020; 10():1398. PubMed ID: 32850451
[No Abstract] [Full Text] [Related]
26. Clinical significance of geriatric nutritional risk index in esophageal squamous cell carcinoma receiving neoadjuvant immunotherapy.
Feng J; Wang L; Yang X; Chen Q; Cheng X
Eur J Surg Oncol; 2024 Jun; 50(6):108323. PubMed ID: 38603867
[TBL] [Abstract][Full Text] [Related]
27. Residual tumor model in esophageal squamous cell carcinoma after neoadjuvant immunochemotherapy: Frequently involves the mucosa and/or submucosa.
Gao L; Hong ZN; Wu L; Yang Y; Kang M
Front Immunol; 2022; 13():1008681. PubMed ID: 36569913
[TBL] [Abstract][Full Text] [Related]
28. A CT-based novel model to predict pathological complete response of locally advanced esophageal squamous cell carcinoma to neoadjuvant PD-1 blockade in combination with chemotherapy.
Zhou HY; Guo WW; Ou J; Li R; Gui Y; Li L; Fu MY; Zhang XM; Chen TW
Eur J Radiol; 2023 Oct; 167():111065. PubMed ID: 37651827
[TBL] [Abstract][Full Text] [Related]
29. Impact of Body Composition on Clinical Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Neoadjuvant Immunotherapy Plus Chemotherapy.
Zhao Y; Xia M; Dang Y; Li Y; Zhao X; Kang N; Zuo J; Zhang R
Ann Ital Chir; 2024; 95(3):284-293. PubMed ID: 38918965
[TBL] [Abstract][Full Text] [Related]
30. Nomogram for Predicting Occult Locally Advanced Esophageal Squamous Cell Carcinoma Before Surgery.
Huang Z; Hong Z; Chen L; Kang M
Front Surg; 2022; 9():917070. PubMed ID: 35774392
[TBL] [Abstract][Full Text] [Related]
31. Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma.
Peng MY; Zuo ZG; Cao FJ; Yu YD; Cai XJ; Wan GX
Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557010
[TBL] [Abstract][Full Text] [Related]
32. Neoadjuvant immune checkpoint inhibitor in combination with chemotherapy or chemoradiotherapy in resectable esophageal cancer: A systematic review and meta-analysis.
Wang H; Li S; Liu T; Chen J; Dang J
Front Immunol; 2022; 13():998620. PubMed ID: 36177019
[TBL] [Abstract][Full Text] [Related]
33. Prognostic value of inflammatory nutritional scores in locally advanced esophageal squamous cell carcinoma patients undergoing neoadjuvant chemoimmunotherapy: a multicenter study in China.
Xu J; Hong Z; Cai Y; Chen Z; Lin J; Yuan X; Chen S; Xie J; Kang M; Ke S
Front Oncol; 2024; 14():1279733. PubMed ID: 38463231
[TBL] [Abstract][Full Text] [Related]
34. Development and Validation of a New Integrative Score Based on Various Systemic Inflammatory and Nutritional Indicators in Predicting Prognosis in Patients With Resectable Esophageal Squamous Cell Carcinoma: A Retrospective Cohort Study.
Feng JF; Wang L; Chen QX; Yang X
Cancer Control; 2022; 29():10732748221091394. PubMed ID: 35410489
[TBL] [Abstract][Full Text] [Related]
35. A Survival Prediction Nomogram for Esophageal Squamous Cell Carcinoma Treated with Neoadjuvant Chemoradiotherapy Followed by Surgery.
Ding T; Liu C; Huang B; Chu L; Wei L; Lin Y; Luo Y; Zhang B; Hong C; Xu Y; Peng Y
Cancer Manag Res; 2021; 13():7771-7782. PubMed ID: 34675672
[TBL] [Abstract][Full Text] [Related]
36. Alleviation of neoadjuvant immunochemotherapy for esophageal squamous cell carcinoma and its relationship with expression and changes of PD-L1.
Zhou YH; Li JY; Yan JX; Guo P; He WW; Liu Y
Neoplasma; 2022 Jul; 69(4):785-793. PubMed ID: 35400168
[TBL] [Abstract][Full Text] [Related]
37. A nomogram based on pretreatment CT radiomics features for predicting complete response to chemoradiotherapy in patients with esophageal squamous cell cancer.
Luo HS; Huang SF; Xu HY; Li XY; Wu SX; Wu DH
Radiat Oncol; 2020 Oct; 15(1):249. PubMed ID: 33121507
[TBL] [Abstract][Full Text] [Related]
38. Clinical significance of Osaka prognostic score based on nutritional and inflammatory status in patients with esophageal squamous cell carcinoma.
Feng J; Wang L; Wang L; Yang X; Lou G
BMC Cancer; 2022 Mar; 22(1):284. PubMed ID: 35300627
[TBL] [Abstract][Full Text] [Related]
39. Prediction of Pathologic Response to Neoadjuvant Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma Incorporating Hematological Biomarkers.
Wu Y; Chen J; Zhao L; Li Q; Zhu J; Yang H; Guo S; Xi M
Cancer Res Treat; 2021 Jan; 53(1):172-183. PubMed ID: 32898941
[TBL] [Abstract][Full Text] [Related]
40. Lymphocyte-monocyte ratio as a predictive marker for pathological complete response to neoadjuvant therapy in esophageal squamous cell carcinoma.
Zhao K; Wang C; Shi F; Li M; Yu J
Transl Cancer Res; 2020 Jun; 9(6):3842-3853. PubMed ID: 35117751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]